CTI BioPharma Corp

NASDAQ:CTIC   3:59:46 PM EDT
3.26
0.00 (-0.15%)
Other Pre-Announcement

CTI BioPharma Reports Q3 Loss Per Share Of $0.15

Published: 11/10/2020 21:18 GMT
CTi Biopharma Corp (CTIC) - Cti Biopharma Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.15.
As of September 30, 2020, Cash, Cash Equivalents and Short-term Investments Totaled $57.4 Million.
Expect Current Cash, Cash Equivalents and Short-term Investments Will Enable to Fund Operations Into Q4 of 2021.
Q3 Earnings per Share View $-0.15 -- Refinitiv Ibes Data (analyst estimates).
No Revenues Were Recognized for Three and Nine Months Ended September 30, 2020.
Q3 Revenue View $0.00 -- Refinitiv Ibes Data (analyst estimates).